Stereotactic radiotherapy for early stage of non - small cell lung cancer
10.11904/j.issn.1002-3070.2018.01.010
- VernacularTitle:早期非小细胞肺癌立体定向放疗的相关研究
- Author:
Mingliang SUN
1
;
Jianyu XU
Author Information
1. 哈尔滨医科大学附属肿瘤医院放疗一科
- Keywords:
Stereotactic radiotherapy;
Early-stage;
Non-small cell lung cancer;
Peripheral;
Central
- From:
Practical Oncology Journal
2018;32(1):53-56
- CountryChina
- Language:Chinese
-
Abstract:
At present,approximately 20% of patients with clinically diagnosed early non-small cell lung cancer(NSCLC) are inoperable for their own reasons.Stereotactic radiotherapy(SRT)has the advantages of short treatment time,mild treatment-relat-ed injury and high local control rate. Currently,it has been used internationally as a first -line treatment for early incapacity of NSCLC.SRT has also achieved encouraging therapeutic effects in the treatment of early-stage NSCLC,but there are also some prob-lems to be solved urgently.This article aims to summarize the dosimetry,clinical indications and radiotherapy injury of SRT in the treatment of early-stage NSCLC.
